EHDS Q&A: Understanding the basics – Part 1
Part 1 of our EHDS Q&A explains why compliance is urgent, outlining key deadlines, enforcement rules, and the financial risks of falling behind.
Resources and expert insights
Check out the latest thinking from our team — explore our blog, read white papers, watch videos, and more.
Viewing results for:
Filter by type
Filter by topic
Search
Read more
EHDS Q&A: Understanding the basics – Part 2
Part 2 of our EHDS Q&A focuses on readiness and implementation, detailing the infrastructure, governance, and changes needed to be ready on time.
How BC Unify works: A conversation on the AI-native platform behind our solutions
Inside BC Unify: how our AI-native platform turns fragmented real-world data into high-quality, research-ready datasets at scale.
What life sciences teams need to know about BC Catalyst
Keith Collier explains how BC Catalyst turns real-world and genomic data into fast, decision-ready insights.
How BC Catalyst accelerates drug development with real-world and genomic data
Keith Collier explains how BC Catalyst uses AI and multimodal data to speed up insights for research, clinical development and precision medicine.
How BC Catalyst accelerates data-driven decision-making: A clinician’s perspective
Dr. Kamal-Uddin outlines the strengths of BC Catalyst in generating insights that move drug development decisions forward.
Oncology real-world evidence: overcoming challenges in Europe and APAC
AI-driven harmonization and SDEs are enabling faster, richer, and more collaborative insights to advance cancer research.
Can real-world data power faster breakthroughs in rare diseases?
Dr. Kamal-Uddin discusses how Real-World Data has the power to transform how we understand and treat rare diseases.
Can TREs actually scale up healthcare data use?
It’s time to rethink how you use Real-World Data: Trusted Research Environments empower faster trials, lower costs, and secure, compliant collaboration.